NOTV Inotiv Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NOTV

Price (delayed)

$4.16

Market cap

$107.29M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.3

Enterprise value

$513.81M

Bioanalytical Systems, Inc., operating as Inotiv, is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies and the world's leading drug development companies and ...

Highlights
Inotiv's EPS has soared by 91% YoY and by 68% from the previous quarter
NOTV's net income has surged by 90% year-on-year and by 68% since the previous quarter
The equity has declined by 9% year-on-year and by 6% since the previous quarter
The debt has grown by 5% YoY and by 2.6% from the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://basinc.com
Peers: NWBO

Key stats

What are the main financial stats of NOTV
Market
Shares outstanding
25.79M
Market cap
$107.29M
Enterprise value
$513.81M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.42
Price to sales (P/S)
0.18
EV/EBIT
132.84
EV/EBITDA
8.63
EV/Sales
0.88
Earnings
Revenue
$585.17M
EBIT
$3.87M
EBITDA
$59.57M
Free cash flow
$6.48M
Per share
EPS
-$1.3
Free cash flow per share
$0.25
Book value per share
$9.85
Revenue per share
$22.71
TBVPS
$17.11
Balance sheet
Total assets
$835.51M
Total liabilities
$581.35M
Debt
$428.52M
Equity
$254.16M
Working capital
$81.2M
Liquidity
Debt to equity
1.69
Current ratio
1.74
Quick ratio
1.02
Net debt/EBITDA
6.82
Margins
EBITDA margin
10.2%
Gross margin
30.3%
Net margin
-5.7%
Operating margin
0%
Efficiency
Return on assets
-3.9%
Return on equity
-12.4%
Return on invested capital
0.5%
Return on capital employed
0.5%
Return on sales
0.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NOTV stock price

How has the Inotiv stock price performed over time
Intraday
6.12%
1 week
-3.03%
1 month
-56.16%
1 year
-25.85%
YTD
13.35%
QTD
-61.97%

Financial performance

How have Inotiv's revenue and profit performed over time
Revenue
$585.17M
Gross profit
$177.23M
Operating income
-$253,000
Net income
-$33.21M
Gross margin
30.3%
Net margin
-5.7%
The operating income has surged by 100% year-on-year and by 100% since the previous quarter
The operating margin has soared by 100% from the previous quarter and by 100% YoY
NOTV's net income has surged by 90% year-on-year and by 68% since the previous quarter
The net margin has soared by 90% YoY and by 69% from the previous quarter

Growth

What is Inotiv's growth rate over time

Valuation

What is Inotiv stock price valuation
P/E
N/A
P/B
0.42
P/S
0.18
EV/EBIT
132.84
EV/EBITDA
8.63
EV/Sales
0.88
Inotiv's EPS has soared by 91% YoY and by 68% from the previous quarter
The P/B is 91% lower than the 5-year quarterly average of 4.8 but 5% higher than the last 4 quarters average of 0.4
The equity has declined by 9% year-on-year and by 6% since the previous quarter
The price to sales (P/S) is 89% less than the 5-year quarterly average of 1.6 and 10% less than the last 4 quarters average of 0.2
Inotiv's revenue has increased by 2.2% QoQ

Efficiency

How efficient is Inotiv business performance
Inotiv's ROS has soared by 105% from the previous quarter and by 101% YoY
The ROIC has soared by 104% QoQ and by 101% YoY
The ROA has soared by 88% YoY and by 68% QoQ
Inotiv's return on equity has surged by 83% YoY and by 68% QoQ

Dividends

What is NOTV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NOTV.

Financial health

How did Inotiv financials performed over time
The total assets is 44% greater than the total liabilities
NOTV's quick ratio is up by 46% year-on-year and by 10% since the previous quarter
Inotiv's current ratio has increased by 12% YoY and by 7% QoQ
The debt is 69% more than the equity
The company's debt to equity rose by 17% YoY and by 9% QoQ
The equity has declined by 9% year-on-year and by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.